Patent · US Active

Treatment of angiopoietin like 7 (ANGPTL7) related diseases

US10941404B2 · kind B2 · utility

1Cited by
5References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 4, 2020
Grant dateMar 9, 2021
Priority date—
Expiry dateSep 4, 2040

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2320/11
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Provided herein are oligonucleotide compositions that inhibit ANGPTL7 and reduce intraocular pressure when administered to an eye. The oligonucleotide compositions contain nucleoside modifications.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.